Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
Clinical trial NCT04350164 · COMPLETED
Trial details
- NCT number
- NCT04350164
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-04-01
- Primary completion
- 2019-12-27
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.